SCHEDULE 13G/A: Rubric Capital Management Discloses 8.25% Stake in QuidelOrtho Corp
Beneficial Ownership Report
Rubric Capital Management LP and its managing member, David Rosen, have disclosed a beneficial ownership of 8.25% in QuidelOrtho Corp's common stock.
Summary
- Rubric Capital Management LP, an investment adviser, and David Rosen, its managing member, collectively reported beneficial ownership of 5,550,000 shares of QuidelOrtho Corp's common stock.
- This stake represents 8.25% of QuidelOrtho Corp's outstanding common stock, based on 67,256,717 shares outstanding as of October 30, 2024.
- The filing, an Amendment No. 1 to Schedule 13G, indicates that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- Rubric Capital Master Fund LP, one of the Rubric Funds, has the right to receive dividends or proceeds from the sale of more than 5% of the Common Stock.
Sentiment
Score: 6
Explanation: The disclosure of a significant institutional stake by Rubric Capital Management LP is generally a neutral to slightly positive signal, indicating confidence from a professional investment firm, without implying activist intent or specific operational changes.
Positives
- The acquisition of an 8.25% stake by an institutional investment adviser like Rubric Capital Management LP signals significant institutional confidence in QuidelOrtho Corp.
- This substantial investment by a professional entity could be viewed positively by the market, potentially indicating a belief in the company's future prospects.
Industry Context
This filing reflects a standard institutional investment disclosure, indicating a significant stake taken by an investment adviser in a healthcare diagnostics company. Such filings are common and provide transparency regarding large ownership positions in publicly traded companies.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor holding an 8.25% stake may influence market perception and potentially share price, signaling institutional confidence.
Key Dates
| Date | Description |
|---|---|
| 2024-10-30 | Date as of which 67,256,717 shares of Common Stock were reported outstanding in the Issuer's Quarterly Report on Form 10-Q. |
| 2024-12-31 | Date of event which requires filing of this statement. |
| 2025-02-13 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
QuidelOrtho Corp, Rubric Capital Management, David Rosen, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.